Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pharmaxis Completes Phase 3 Trial Of Bronchitol
The double blind, placebo controlled, randomised study comparing 400mg of Bronchitol twice a day to control included 305 participants, and was conducted across 53 sites in 7 countries.
The double blind, placebo controlled, randomised study comparing 400mg of Bronchitol twice a day to control included 305 participants, and was conducted across 53 sites in 7 countries.
Required for FDA new drug application (NDA) submission, this combination rule study – comparing the efficacy and safety profiles of MoxDuoIR against component doses of morphine and oxycodone
The collaboration aims to promote the value of the unique Hunt Study, which for the past 25 years has gathered blood samples from the general population of the
Chronix researchers have published data demonstrating that the company’s techniques which can accurately detect BSE in cattle before any disease symptoms are evident. Currently BSE can be definitively
Pancreaze (pancrelipase) delayed-release capsules are indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. Pancreaze is a combination of porcine-derived lipases, proteases,
As part of the agreement, Access Genetics will incorporate web-based software, materials and protocols that Access Genetics developed specifically for use with the LabChip GX and market the
Mersana plans to initiate a Phase 1 clinical trial for XMT-1107 in the second quarter of 2010. XMT-1107 is expected to be the company’s second oncology product to
Access plans to use the initial batches of MuGard for pre-launch key institution evaluations, preliminary stock for select wholesalers and specialty distributors, and additional post-approval studies to be
GBIL expects to introduce the genetic test to all Svenson Hair Centres in Hong Kong and Singapore. HairDX’s easy to use genetic test provides an understandable genetic analysis
Under the terms of the three-year agreement, Premier members will continue to have access to specially negotiated pricing for automation, general chemistry, immunoassay and integrated work cell products